Vimarsana
Biggest News Aggregation in the World

Page 6 - Preclinical Data News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Preclinical Data. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Preclinical Data Today - Breaking & Trending Today

Cali Biosciences Announces Publications of Phase IIa Results of Long-Acting Ropivacaine (CPL-01) - Vimarsana News

Cali Biosciences Announces Publications of Phase IIa Results of Long-Acting Ropivacaine (CPL-01)

/PRNewswire/ -- Cali Biosciences Co., Ltd. (hereinafter referred to as "Cali Biosciences"), a biopharmaceutical company focused on the research and development...

Preclinical Data from iECURE's GTP-506 Demonstrates Potential for the Treatment of Ornithine Transcarbamylase (OTC) Deficiency | DNA RNA and Cells - Vimarsana News

Preclinical Data from iECURE's GTP-506 Demonstrates Potential for the Treatment of Ornithine Transcarbamylase (OTC) Deficiency | DNA RNA and Cells

Preclinical Data from iECURE’s GTP-506 Demonstrates Potential for the Treatment of Ornithine Transcarbamylase (OTC) Deficiency

Ryvu Therapeutics Reports 2022 Half-Year Financial Results and Provides Corporate Update - Vimarsana News

Ryvu Therapeutics Reports 2022 Half-Year Financial Results and Provides Corporate Update

/PRNewswire/ -- Ryvu Therapeutics (WSE: RVU), a clinical-stage drug discovery and development company focusing on novel small molecule therapies that address...

Ryvu Therapeutics Reports 2022 Half-Year Financial Results and Provides Corporate Update - Vimarsana News

Ryvu Therapeutics Reports 2022 Half-Year Financial Results and Provides Corporate Update

/PRNewswire/ -- Ryvu Therapeutics (WSE: RVU), a clinical-stage drug discovery and development company focusing on novel small molecule therapies that address...

Nuvalent to Present Preliminary Phase 1 Data from ARROS-1 Clinical Trial of NVL-520 at 34th EORTC-NCI-AACR Symposium and Announces Pipeline Updates - Vimarsana News

Nuvalent to Present Preliminary Phase 1 Data from ARROS-1 Clinical Trial of NVL-520 at 34th EORTC-NCI-AACR Symposium and Announces Pipeline Updates

Preliminary Dose Escalation Data on ROS1-selective Inhibitor NVL-520 to be Presented in the "New Drugs on the Horizon" Oral Plenary Session New Preclinical...